Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
$0.80
-3.2%
$1.71
$0.69
$13.50
$3.94M-1.33535,698 shs172,826 shs
Callan JMB Inc. stock logo
CJMB
Callan JMB
$0.79
+4.1%
$0.88
$0.65
$5.88
$4.29M-0.06334,790 shs48,068 shs
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
$0.74
+13.8%
$1.13
$0.49
$16.12
$3.82M1.77236,599 shs109,640 shs
OCG
Oriental Culture
$1.71
-1.2%
$1.92
$1.51
$12,731.40
$1M0.41696,835 shs85,007 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
-3.18%-0.79%-51.88%-79.02%-90.95%
Callan JMB Inc. stock logo
CJMB
Callan JMB
+4.08%+12.60%+8.36%-36.72%-84.02%
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
+11.28%+5.94%-38.84%-39.34%-83.63%
OCG
Oriental Culture
-1.16%-8.06%-8.06%-9.52%+170,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
$0.80
-3.2%
$1.71
$0.69
$13.50
$3.94M-1.33535,698 shs172,826 shs
Callan JMB Inc. stock logo
CJMB
Callan JMB
$0.79
+4.1%
$0.88
$0.65
$5.88
$4.29M-0.06334,790 shs48,068 shs
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
$0.74
+13.8%
$1.13
$0.49
$16.12
$3.82M1.77236,599 shs109,640 shs
OCG
Oriental Culture
$1.71
-1.2%
$1.92
$1.51
$12,731.40
$1M0.41696,835 shs85,007 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
-3.18%-0.79%-51.88%-79.02%-90.95%
Callan JMB Inc. stock logo
CJMB
Callan JMB
+4.08%+12.60%+8.36%-36.72%-84.02%
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
+11.28%+5.94%-38.84%-39.34%-83.63%
OCG
Oriental Culture
-1.16%-8.06%-8.06%-9.52%+170,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
1.00
SellN/AN/A
Callan JMB Inc. stock logo
CJMB
Callan JMB
1.00
SellN/AN/A
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
1.00
SellN/AN/A
OCG
Oriental Culture
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest OCG, CJMB, BIAF, and FTFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2026
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
Reiterated RatingSell (E+)
4/29/2026
Callan JMB Inc. stock logo
CJMB
Callan JMB
Reiterated RatingSell (E+)
4/22/2026
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
DowngradeSell (D-)Sell (E+)
(Data available from 6/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
$6.16M0.62N/AN/A$1.62 per share0.50
Callan JMB Inc. stock logo
CJMB
Callan JMB
$5.72M0.78N/AN/A$0.50 per share1.58
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
$3.83M1.13N/AN/A$8.71 per share0.08
OCG
Oriental Culture
$1.89M0.52N/AN/A$111.57 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
-$14.91M-$11.77N/AN/AN/A-280.53%-285.75%-143.71%8/19/2026 (Estimated)
Callan JMB Inc. stock logo
CJMB
Callan JMB
-$7.97M-$2.07N/AN/AN/A-184.70%-285.36%-141.01%N/A
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
-$4.62M-$3.17N/AN/AN/A-37.76%-13.08%-10.33%N/A
OCG
Oriental Culture
-$3.86MN/AN/AN/AN/AN/AN/AN/AN/A

Latest OCG, CJMB, BIAF, and FTFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Callan JMB Inc. stock logo
CJMB
Callan JMB
N/A-$0.59N/A-$0.59N/A$1.11 million
5/15/2026Q1 2026
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
N/A-$0.25N/A-$0.25N/A$0.21 million
5/14/2026Q4 2025
OCG
Oriental Culture
N/A$9.0760N/A$9.0760N/A$0.87 million
5/8/2026Q1 2026
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
-$2.40-$0.81+$1.59-$0.81$1.48 million$1.35 million
3/31/2026Q4 2025
Callan JMB Inc. stock logo
CJMB
Callan JMB
N/A-$0.56N/A-$0.56N/A$1.16 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
N/AN/AN/AN/AN/A
Callan JMB Inc. stock logo
CJMB
Callan JMB
N/AN/AN/AN/AN/A
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
N/AN/AN/AN/AN/A
OCG
Oriental Culture
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
0.15
1.36
1.34
Callan JMB Inc. stock logo
CJMB
Callan JMB
N/A
2.00
1.86
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
N/A
6.82
6.82
OCG
Oriental Culture
N/A
30.15
29.85

Institutional Ownership

CompanyInstitutional Ownership
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
1.64%
Callan JMB Inc. stock logo
CJMB
Callan JMB
N/A
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
0.19%
OCG
Oriental Culture
1.58%

Insider Ownership

CompanyInsider Ownership
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
2.68%
Callan JMB Inc. stock logo
CJMB
Callan JMB
73.87%
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
1.50%
OCG
Oriental Culture
23.87%
CompanyEmployeesShares OutstandingFree FloatOptionable
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
104.74 million4.62 millionNot Optionable
Callan JMB Inc. stock logo
CJMB
Callan JMB
355.65 million1.48 millionN/A
Future FinTech Group Inc. stock logo
FTFT
Future FinTech Group
705.87 million5.78 millionNo Data
OCG
Oriental Culture
50580,000441,000N/A

Recent News About These Companies

Oriental Culture Holding Ltd
Oriental Culture Holding Appoints New Chairman

New MarketBeat Followers Over Time

Media Sentiment Over Time

bioAffinity Technologies stock logo

bioAffinity Technologies NASDAQ:BIAF

$0.80 -0.03 (-3.18%)
Closing price 06/29/2026 04:00 PM Eastern
Extended Trading
$0.82 +0.01 (+1.54%)
As of 06/29/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

Callan JMB stock logo

Callan JMB NASDAQ:CJMB

$0.79 +0.03 (+4.08%)
Closing price 06/29/2026 04:00 PM Eastern
Extended Trading
$0.76 -0.03 (-3.79%)
As of 06/29/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility. We view our solutions as disruptive to the “older technologies” of dry ice and liquid nitrogen, in that our solutions are comprehensive and combine our competencies in configurations that are customized to our client’s requirements. We provide comprehensive, reliable, and economic alternatives to all existing logistics solutions and services utilized for frozen shipping in the life sciences industry (e.g., personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). As part of our services, we provide the ability to monitor, record and archive crucial information for each shipment that can be used for scientific and regulatory purposes. Our Ship2Q® ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturer specifications equal to new “off-the-shelf” shipper systems. Our systematic Ship2Q® process meets all good current manufacturing practices (“cGMP”) and good current distribution practices (“cGDP”) compliance standards and generates shipper specific track and trace documentation key to any deployment and reuse. Ship2Q® applies a system of control over the recovery and reuse phase of the logistics loop. We are able to recover and reuse the Greenbox shipper, amortizing its total cost across numerous shipments making it cost-neutral in the first few cycles. Additionally, our sophisticated cloud-based logistics operating platform, which is branded as our “Sentry” system, integrates GPS and precise temperature diagnostics throughout a package’s journey, maintaining the efficacy, safety, and quality of temperature-sensitive goods throughout transit—with zero bench time required. The Sentry system supports the management of the entire shipment and logistics process through a single interface, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. In addition, it provides unique and incisive information dashboards and validation documentation for every shipment. The Sentry platform records and retains a fully documented “chain-of-custody” and, at the client’s option, “chain-of-condition” for every shipment, helping ensure that quality, safety, efficacy, and stability of shipped commodities are maintained throughout the process. This recorded and archived information allows our clients to meet exacting requirements necessary for scientific work and for proof of regulatory compliance during the logistics phase. With extensive experience in quality assurance and quality control, we deliver reliability by anticipating, responding, and overcoming the most complex situations with precision and compassion, providing peace of mind and a comprehensive solution for our customers. This empowers the healthcare and emergency response industries with solutions to ensure temperature-sensitive goods remain within specified parameters throughout transit through tracking mechanisms and predictive technology to ensure its integrity for patients, providers, and their communities. We were originally formed as Coldchain Technology Services, LLC, a Texas limited liability company. We reorganized as a holding company to Callan JMB Inc., a Nevada corporation, on February 14 2024. We are headquartered at 244 Flightline Dr., Spring Branch, TX 78070.

Future FinTech Group stock logo

Future FinTech Group NASDAQ:FTFT

$0.74 +0.09 (+13.78%)
As of 06/29/2026 04:00 PM Eastern

Future FinTech Group Inc., through its subsidiaries, operates online shopping platforms in People's Republic of China. It operates in three segments: Supply Chain Financing Service and Trading Business, Asset Management Service, and Others. The company offers cross-border money transfer service, brokerage and investment banking, and cryptocurrency mining farm business. It also engages in the trading of coal, aluminum ingots, sand, and steel; and E-commerce, digital wallet safety management, blockchain code auditing and operations, cryptocurrency mining, metaverse and big data maintenance services. The company was formerly known as SkyPeople Fruit Juice, Inc. and changed its name to Future FinTech Group Inc. in June 2017. Future FinTech Group Inc. is headquartered in New York, New York.

Oriental Culture NASDAQ:OCG

$1.71 -0.02 (-1.16%)
Closing price 06/29/2026 04:00 PM Eastern
Extended Trading
$1.75 +0.04 (+2.40%)
As of 06/29/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oriental Culture Holding LTD, through its subsidiaries, operates an online platform to facilitate e-commerce of artwork trading in China. The company facilitates trading by individual and institutional customers of various collectibles, artworks, and commodities on its online platforms. It also provides online and offline integrated marketing, storage, and technical maintenance services, as well as industry solutions and related software products and system development services. The company was founded in 2018 and is headquartered in Central, Hong Kong.